Pulse Biosciences, Inc. Additional Paid in Capital, Common Stock
Pulse Biosciences, Inc. (PLSE) had Additional Paid in Capital, Common Stock of $605.95 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $605.95M.
- 2026-03-31: Additional Paid in Capital, Common Stock $548.09M.
- 2025-12-31: Additional Paid in Capital, Common Stock $543.87M.
- 2025-09-30: Additional Paid in Capital, Common Stock $538.47M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $605.95M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $548.09M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $543.87M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $538.47M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $530.88M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $525.68M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $505.30M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $450.18M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $385.35M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $383.28M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $381.22M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $377.07M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $374.86M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $293.80M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $292.42M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $291.66M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $290.85M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $274.24M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $381.22M 10-Q · filed 2024-10-30 | $271.86M 10-K · filed 2022-03-31 |
| 2021-09-30 | $268.14M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $266.22M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $211.55M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $195.41M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $191.47M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $188.20M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $156.29M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $153.40M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $149.85M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $146.97M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $144.89M 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $142.03M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $94.83M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $91.03M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $87.92M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $84.20M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $79.39M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $46.13M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $43.13M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $37.90M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $37.66M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $37.48M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $16.94M 10-Q · filed 2016-06-27 | |
| 2015-12-31 | $16.75M 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |